the challenge of a universal vaccine for Lyon start-up Osivax

Targeting a virus protein that does not mutate slightly, this is the approach to Osivax, which drives the development of vaccines against influenza and against coronavirus. Explanations.

By Dominique MENVIELLE – 06:00 – Reading time: